STOCK TITAN
  1. Home
  2. Sec-filings
  3. VIR
  4. [144] Vir Biotechnology, Inc. SEC Filing

[144] Vir Biotechnology, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock VIR logo
Vir Biotechnology, Inc.

NASDAQ:VIR

VIR Rankings

#2968 Ranked by Market Cap
N/A Ranked by Dividends

VIR Latest News

Aug 25, 2025
Vir Biotechnology to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
Aug 6, 2025
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Aug 6, 2025
Vir Biotechnology Successfully Initiates all Trials in ECLIPSE Registrational Program for Chronic Hepatitis Delta
Jul 31, 2025
Vir Biotechnology Initiates Second Pivotal Trial in Its Global ECLIPSE Registrational Program for Chronic Hepatitis Delta
Jul 24, 2025
Vir Biotechnology Announces First Patient Dosed in Phase 1 Clinical Trial of EGFR-Targeting PRO-XTEN™ Dual-Masked T-Cell Engager VIR-5525 for the Treatment of Solid Tumors

VIR Latest SEC Filings

Sep 3, 2025
[Form 4] Vir Biotechnology, Inc. Insider Trading Activity
Aug 6, 2025
[10-Q] Vir Biotechnology, Inc. Quarterly Earnings Report
Aug 4, 2025
[Form 4] Vir Biotechnology, Inc. Insider Trading Activity
Jul 24, 2025
[8-K] Vir Biotechnology, Inc. Reports Material Event
Jul 17, 2025
[Form 4] Vir Biotechnology, Inc. Insider Trading Activity

VIR Stock Data

714.03M
105.26M
10.51%
81.8%
8.02%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SAN FRANCISCO